BIOMAT Database Logo BIOMAT Database Logo

A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. 1983

L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto

During a double-blind trial in which patients with suspected myocardial infarction received metoprolol or placebo, we analyzed the occurrence of ventricular tachyarrhythmias. Metoprolol (15 mg intravenously) was given as soon as possible after admission, and thereafter 200 mg was given daily for three months. Antiarrhythmic drugs were given only for ventricular fibrillation and sustained ventricular tachycardia (greater than 60 beats per second). Definite acute myocardial infarction developed in 809 of the 1395 participants, and probable infarction in 162. Metoprolol did not influence the occurrence of premature ventricular contractions or short bursts of ventricular tachycardia. However, there were 17 cases of ventricular fibrillation in the placebo group (697 patients) and only 6 in the metoprolol group (698 patients, P less than 0.05). During the hospital stay significantly fewer patients receiving metoprolol (16) than placebo (38) (P less than 0.01) required lidocaine. In a separate analysis of 145 patients, metoprolol did not influence the occurrence of premature ventricular contractions or short bursts of ventricular tachycardia during the first 24 hours of treatment. Despite a lack of effect on less serious ventricular tachyarrhythmias, metoprolol had a prophylactic effect against ventricular fibrillation in acute myocardial infarction.

UI MeSH Term Description Entries
D008297 Male Males
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013610 Tachycardia Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia. Tachyarrhythmia,Tachyarrhythmias,Tachycardias

Related Publications

L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.
October 1981, Lancet (London, England),
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
[Effect on mortality of metoprolol in acute myocardial infarction. A randomized double-blind trial (author's transl)].
January 1982, MMW, Munchener medizinische Wochenschrift,
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
Relationship between infarct size and incidence of severe ventricular arrhythmias in a double-blind trial with metoprolol in acute myocardial infarction.
July 1984, International journal of cardiology,
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
Alprenolol in acute myocardial infarction: Double-blind trial.
March 1970, The New Zealand medical journal,
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
A double-blind trial of lidocaine in acute myocardial infarction.
August 1973, The Medical journal of Australia,
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial.
September 1971, British medical journal,
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
The effects of metoprolol given early in acute myocardial infarction on ventricular arrhythmias.
March 1986, European heart journal,
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
[Effect of metoprolol on infarct size after acute myocardial infarction (a double-blind study) (author's transl)].
August 1982, Deutsche medizinische Wochenschrift (1946),
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction.
June 1983, Circulation,
L Rydén, and R Ariniego, and K Arnman, and J Herlitz, and A Hjalmarson, and S Holmberg, and C Reyes, and P Smedgård, and K Svedberg, and A Vedin, and F Waagstein, and A Waldenström, and C Wilhelmsson, and H Wedel, and M Yamamoto
Treatment of ventricular extrasystoles and tachyarrhythmias in acute myocardial infarction.
January 1970, Annual review of medicine,
Copied contents to your clipboard!